Swiss National Bank Cuts Stock Holdings in Cigna Group $CI

Swiss National Bank decreased its position in shares of Cigna Group (NYSE:CI) by 5.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 731,501 shares of the health services provider’s stock after selling 38,600 shares during the period. Swiss National Bank’s holdings in Cigna Group were worth $201,331,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in CI. Norges Bank purchased a new stake in shares of Cigna Group during the fourth quarter valued at approximately $1,019,790,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Cigna Group by 13,333.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after buying an additional 3,141,844 shares during the last quarter. Capital Research Global Investors grew its holdings in shares of Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after buying an additional 1,855,897 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after buying an additional 903,334 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its holdings in shares of Cigna Group by 54.5% during the third quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after buying an additional 753,865 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Down 0.4%

CI stock opened at $294.64 on Friday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The business’s 50-day moving average is $281.93 and its two-hundred day moving average is $277.87. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market cap of $77.94 billion, a price-to-earnings ratio of 12.49, a P/E/G ratio of 1.14 and a beta of 0.28.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same period last year, the firm earned $6.74 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts forecast that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the topic of a number of recent analyst reports. The Goldman Sachs Group increased their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, June 6th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Mizuho increased their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday. Finally, Royal Bank Of Canada increased their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $338.80.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.